According to Benzinga Pro, Ciena's peer group average for short interest as a percentage of float is 6.64%, which means the company has less short interest than most of its peers. Did you know that ...
What Happened: In a recent Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, Swallow, President & CEO at Idaho Strategic Resources, acquired 23,000 stock options for IDR with ...
During Thursday's morning session, Incyte shares down by 0.19%, currently priced at $72.27. Considering the current price, Tray's 3,432 shares have a total value of $1,166.
Buying $100 In MELI: If an investor had bought $100 of MELI stock 10 years ago, it would be worth $1,417.14 today based on a price of $1814.93 for MELI at the time of writing.
Sui's (CRYPTO: SUI) price has decreased 3.64% over the past 24 hours to $4.41, continuing its downward trend over the past week of -6.0%, moving from $4.63 to its current price.
Walmart raises bonuses and stock awards for regional store managers to up to $600,000 as employers struggle to fill roles, while reducing perks for office staff.
Union Pacific reported mixed Q4 results, with a decline in operating revenue and a 7% increase in EPS. Outlook includes growth in earnings and efficiency.
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 50 points on Thursday. Following the market ...
Founder & CEO of Professional Capital Management Anthony Pompliano on Thursday said “more than 50%” of President Donald Trump ...
The Q4 earnings report for Freeport-McMoRan FCX was released on Thursday, January 23, 2025 at 08:00 AM. Here's what investors need to know about the latest announcement. Freeport-McMoRan beat ...
Independent Bank IBCP reported its Q4 earnings results on Thursday, January 23, 2025 at 08:00 AM. Here's what investors need to know about the announcement. Independent Bank beat estimated earnings by ...
Ascendis Pharma ASND has outperformed the market over the past 10 years by 37.07% on an annualized basis producing an average annual return of 48.79%. Currently, Ascendis Pharma has a market ...